- PhD in Molecular Biology, University of Barcelona
- Advanced Management Program (AMP), ESADE
- Global Growth Strategy, Business Opportunities and Financial Challenges Program, Wharton School
- Master of Statiscs in Heatlh sciences, Autonomous
Between 2019 to 2023 she lead BHV Partners as a Chief Executive Officer (CEO). In January 2024, she will take charge of Director of Consultancy, a strategic business division for BHV Partners that requires an executive profile with broad experience in the sector.
For more than 25 years, she has held executive positions in research, the biopharmaceutical business, innovation and entrepreneurship.
She has vast experience in drug discovery and development and has led the CNS Pharmacology department at Grupo Ferrer, where she created new research opportunities and projects that generated different patents with two products that reach clinical trials.
Between 2008 and 2012, she was director of Innovation at Biocat, the Catalan biocluster where she promoted entreprenurship initiatives, training programs and leading reports in the BioRegion of Catalonia.
She subsequently became CEO of the GAEM Foundation, as well as head of its accelerator in multiple sclerosis projects, head of the Entrepreneurship and Innovation at Bellavista Legal, and head of Operations at ADVentura Capital, where she promoted the internationalisation of the start-ups.
She is mentor at several accelerations programs and speaker in start-up summits and events.